U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07864662) titled 'Impact of Trout Fish, Cow Milk With Egg, Vitamin D Supplementation, and Dietary Education on... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembr... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral ner... Read More
U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866820) titled 'Effect of Automated Oxygen Control on Early-childhood Lung Mechanics' on Sept. 25. Brief Su... Read More
U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866703) titled 'Thumb Muscle Activation During Different Activities of Daily Living in Thumb Base Osteoarthr... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantini... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combine... Read More